Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration
Author:
Affiliation:
1. IBD Centre, Humanitas Clinical and Research Centre, Rozzano, Milan, Italy
2. Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy
Funder
F. Hoffmann-La Roche Ltd
Takeda Development Center Americas, Inc
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,General Medicine
Link
http://academic.oup.com/ecco-jcc/article-pdf/12/suppl_2/S678/25526380/jjx107.pdf
Reference98 articles.
1. Etiopathogenesis of inflammatory bowel diseases;Danese;World J Gastroenterol,2006
2. Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management;Dulai;Cancer Prev Res [Phila],2016
3. New therapies for inflammatory bowel disease: from the bench to the bedside;Danese;Gut,2012
4. Strategies that target leukocyte traffic in inflammatory bowel diseases: recent developments;Rivera-Nieves;Curr Opin Gastroenterol,2015
5. Expression and function of the MADCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes;Erle;J Immunol,1994
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intestinal epithelial vitamin D receptor defense against inflammatory bowel disease via regulating microfold cells;Immunology Letters;2024-12
2. Pharmacokinetics of S1P receptor modulators in the treatment of ulcerative colitis;Expert Opinion on Drug Metabolism & Toxicology;2024-09-12
3. The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function;Frontiers in Pharmacology;2024-08-19
4. From serum metabolites to the gut: revealing metabolic clues to susceptibility to subtypes of Crohn’s disease and ulcerative colitis;Frontiers in Endocrinology;2024-08-08
5. Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3